RIKEN VITAMIN CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,610 JPY | -2.72% |
|
-3.87% | +16.78% |
| Feb. 29 | Riken Vitamin Buys Back Shares Worth Over 6 Billion Yen | MT |
| Feb. 29 | Riken Vitamin, Kikkoman End Raw Materials Partnership | MT |
Strengths
- With a P/E ratio at 9.58 for the current year and 11.16 for next year, earnings multiples are highly attractive compared with competitors.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Sector: Food Processing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.78% | 536M | - | - | |
| -5.49% | 264B | A- | ||
| -2.13% | 93.8B | C+ | ||
| -3.16% | 43.4B | C+ | ||
| +0.07% | 40.18B | B- | ||
| +6.29% | 39.74B | B- | ||
| +7.32% | 39.03B | B- | ||
| -14.72% | 29.76B | B- | ||
| -5.68% | 28.39B | A | ||
| +13.52% | 25.09B | A- |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4526 Stock
- Ratings Riken Vitamin Co., Ltd.